Global Dengue Testing Market Size to Exceed USD 1102.3 Million by 2035 | CAGR of 5.37%
Category: HealthcareGlobal Dengue Testing Market Size to Exceed USD 1102.3 Million by 2035
According to a research report published by Spherical Insights & Consulting, The Global Dengue Testing Market Size is Expected to Grow from USD 619.8 Million in 2024 to USD 1102.3 Million by 2035, at a CAGR of 5.37% during the forecast period 2025-2035.
Get more details on this report -
Browse 250 Market Data Tables And 119 Figures Spread Through Pages and In-Depth TOC On the "The Global Dengue Testing Market Size, Share, and COVID-19 Impact Analysis, By Product Scope (ELISA-based Tests, Dengue IgG/IgM Detection Kits, RT-PCR Tests, Rapid Diagnostic Tests (RDTs), NS1 Antigen Detection Kits, and Lateral Flow Immunoassay), By End-use (Clinical Labs, Hospitals /Clinics, and Home Healthcare), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/dengue-testing-market
The dengue testing market includes diagnostic tools and services used to detect dengue virus infections, including rapid tests, ELISA, and PCR, catering to hospitals, clinics, and diagnostic laboratories globally. A major public health concern is the increase in dengue fever infections worldwide, particularly in areas like Asia and Latin America, where urbanization and climate change encourage the spread of Aedes mosquitoes. The need for efficient infrastructure for testing and treatment has increased as a result of this spike in cases. Particularly in regions with limited healthcare resources, technological developments, notably in point-of-care testing (POCT), have greatly improved diagnostic speed and accuracy. Better outbreak control and speedier clinical judgments are made possible by these advancements. At the same time, government-led programs like India's NVBDCP are increasing diagnostic capacity and raising public awareness, which will improve healthcare readiness. In order to promote early detection and improved control, these programs encourage higher testing volumes and raise demand for contemporary diagnostic instruments. Together, these developments are speeding up the market for expansion and innovation. The inability of current dengue tests, such as NS1 and IgM/IgG assays, to accurately predict severity leads to misdiagnosis, needless hospitalizations, and confusion with related viruses, including leptospirosis and chikungunya.
The ELISA-based tests segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product scope, the dengue testing market is divided into ELISA-based tests, dengue IgGIgM detection Kits, RT-PCR tests, rapid diagnostic tests (RDTs), NS1 antigen detection kits, and lateral flow immunoassay. Among these, the ELISA-based tests segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. These tests are highly recommended because they accurately detect dengue-specific antibodies, such as IgM and IgG, which aid in determining the infection stage. Their capacity to reliably identify dengue viral antigens at an early stage of infection makes them an essential tool for managing the disease. Developments in ELISA technology and the growing need for precise and effective diagnostic solutions are driving the sector expansion of the worldwide dengue testing market.
The clinical labs segment accounted for the fastest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end use, the dengue testing market is divided into clinical labs, hospitals clinics, and home healthcare. Among these, the clinical labs segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.Significant players including LabCorp and Quest Diagnostics from North America have included dengue RT-PCR into their infectious disease panels, and networks of private laboratories from India and Brazil offered multiplex testing during surge seasons. Public health initiatives are also implementing consolidated surveillance testing in regional reference laboratories, which is promoting increased test volumes as well.
North America is expected to hold the majority share of the global dengue testing market during the forecast period.
Get more details on this report -
The rising number of dengue cases linked to travel and the rising danger of local transmission in some areas are driving the dengue testing market's expansion in North America. The likelihood of a dengue outbreak has increased due to the expansion of mosquitoes brought on by warm temperatures and climate change. Key markets include the US and Mexico, with Mexico bearing a disproportionately high caseload because of its tropical environment. Early identification and illness management are enhanced by developments in diagnostic technologies, such as molecular assays and quick antigen tests. The necessity for dengue testing is effectively supported by government programs aiming at vector management and surveillance, as well as increased healthcare knowledge.Asia Pacific is anticipated to grow at the fastest pace in the global dengue testing market during the forecast period. Climate change is changing mosquito breeding patterns and disease transmission, which is contributing to the increase in dengue cases across the Asia Pacific. Mosquitoes thrive in environments with rising temperatures, excessive humidity, and more rainfall.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In August 2024, J Mitra & Company introduced the Dengue NS1 Antigen self-test kit, India's first home-use diagnostic tool for dengue. This kit enables individuals to conduct tests independently, providing results within 20 minutes with easy visual interpretation.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the dengue testing market based on the below-mentioned segments:
Global Dengue Testing Market, By Product Scope
- ELISA-based Tests,
- Dengue IgG/IgM Detection Kits
- RT-PCR Tests
- Rapid Diagnostic Tests (RDTs)
- NS1 Antigen Detection Kits
- Lateral Flow Immunoassay
Global Dengue Testing Market, By End Use
- Clinical Labs
- Hospitals /Clinics
- Home Healthcare
Global Dengue Testing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?